Biblio
Export 230 results:
Author Title Type [ Year
Filters: First Letter Of Title is E [Clear All Filters]
“Is Engagement in Intellectual and Social Leisure Activities Protective Against Dementia Risk? Evidence from the English Longitudinal Study of Ageing.”, J Alzheimers Dis, vol. 80, no. 2, pp. 555-565, 2021.
, “Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.”, J Alzheimers Dis, vol. 84, no. 1, pp. 119-128, 2021.
, “Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
, “Ethnic Differences in Dementia Risk: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 80, no. 1, pp. 337-355, 2021.
, “Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1413-1428, 2021.
, “Effect of Mentally Challenging Occupations on Incident Dementia Differs Between African Americans and Non-Hispanic Whites.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1405-1416, 2020.
, “The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.”, J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
, “Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 3, pp. 903-910, 2020.
, “Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”, J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
, “Estrogens Inhibit Amyloid-β-Mediated Paired Helical Filament-Like Conformation of Tau Through Antioxidant Activity and miRNA 218 Regulation in hTau Mice.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1339-1351, 2020.
, “Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1437-1446, 2020.
, “Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1117-1127, 2020.
, “An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1085-1103, 2020.
, “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
, “Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults.”, J Alzheimers Dis, vol. 72, no. 2, pp. 495-506, 2019.
, “Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 72, no. 1, pp. 191-197, 2019.
, “The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.”, J Alzheimers Dis, vol. 70, no. 3, pp. 861-875, 2019.
, “Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1311-1316, 2019.
, “Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.”, J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
, “Evaluation of Medicare Claims Data as a Tool to Identify Dementia.”, J Alzheimers Dis, vol. 67, no. 2, pp. 769-778, 2019.
, “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
, “Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
, “Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models.”, J Alzheimers Dis, vol. 62, no. 1, pp. 347-359, 2018.
,